The bird flu vaccine isn’t available in the US

Published 2023년 4월 7일

Tridge summary

The United States is not prepared for vaccinations against High Pathogenicity Avian Influenza (HPAI) due to the lack of a vaccine that matches the virus. The country is relying on biosecurity measures to contain the virus, which has been detected in wild aquatic birds, commercial poultry, and backyard flocks since January 2022. The virus has spread to 47 states, leading to the destruction of 58,645,211 birds. The virus has also been detected in Chile, marking the second human case of H5N1 in South America. The source of infection for the Chilean patient is under investigation.

Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The United States is not ready to vaccinate against High Pathogenicity Avian Influenza (HPAI). According to John R. Clifford, veterinary trade policy advisory for the USA Poultry & Egg Export Council, an approved vaccine is not yet available that is a “good match to the virus.” That leaves biosecurity measures as the best U.S. weapon against the virus. Clifford, who is scheduled to speak at the upcoming Chicken Marketing Summit, says the worst-case scenario would be the continuation of the current situation for “many years.” The Chicken Marketing Summit is scheduled for July 31 to Aug. 2 in Miramar Beach, FL. Vaccinations against HPAI are being used in Mexico, China, Egypt and Vietnam. The highly pathogenic avian influenza (HPAI) viruses have been detected in U.S. wild aquatic birds, commercial poultry, and backyard or hobbyist flocks since January 2022, causing the destruction of 58,645,211 birds. These are the first detections of HPAI viruses A (H5N1) in the U.S. since 2016. The ...

Source: Foodsafetynews